{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:37:51Z","timestamp":1793277471407,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000},"content-version":"vor","delay-in-days":115,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>GM1 gangliosidosis is an inherited, progressive, and fatal neurodegenerative lysosomal storage disorder with no approved treatment. In this study, we present the first use of MRI-based predicted brain age in GM1 gangliosidosis aimed at assessing the neuronal degeneration in this cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We calculated a predicted brain age and Brain Structures Age Gap Estimation (BSAGE) for 81 MRI scans from 41 Type II (26 juvenile and 15 late-infantile) GM1 gangliosidosis patients and 897 MRI scans from 556 neurotypical controls (NC) utilizing\n                      <jats:italic>BrainStructuresAges<\/jats:italic>\n                      , a machine learning MRI analysis pipeline.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NC shows whole-brain aging at a rate of 0.83 per chronological year compared with 1.57 in juvenile GM1 patients and 12.25 in late-infantile GM1 patients. Accelerated and distinct brain aging is observed throughout midbrain structures, including the thalamus and caudate nucleus, hindbrain structures, including the cerebellum and brainstem, and the ventricles in juvenile and late-infantile GM1 patients compared to NC, reflecting neurodegeneration from disease progression. Cross-sectional evaluations of BSAGE for the whole brain show an average BSAGE\u2009=\u200935.50 years in the late-infantile cohort, 21.19 years in the juvenile cohort, and 0.03 years in NC. Predicted brain age and BSAGE both correlate with cross-sectional and longitudinal clinical outcome assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Predicted brain age accurately reflects the neurodegenerative clinical trajectories of the Type II GM1 disease subtypes. Correlations with clinical outcome assessments indicate evaluations of predicted brain aging may be an important candidate neuroimaging outcome measure for clinical trials in GM1 gangliosidosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-026-01745-w","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:36:31Z","timestamp":1783355791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brain aging in Type II GM1 gangliosidosis"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-5848","authenticated-orcid":false,"given":"Connor J.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selby I.","family":"Chipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precilla","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0831-8462","authenticated-orcid":false,"given":"Muhammad H.","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-7401","authenticated-orcid":false,"given":"Maria T.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1745_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","volume":"94","author":"N Brunetti-Pierri","year":"2008","unstructured":"Brunetti-Pierri, N. & Scaglia, F. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol. Genet. Metab. 94, 391\u2013396 (2008).","journal-title":"Mol. Genet. Metab."},{"key":"1745_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2018.01.002","volume":"156","author":"R Sandhoff","year":"2018","unstructured":"Sandhoff, R., Schulze, H. & Sandhoff, K. Ganglioside metabolism in health and disease. Prog. Mol. Biol. Transl. Sci. 156, 1\u201362 (2018).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"1745_CR3","doi-asserted-by":"publisher","unstructured":"Sipione, S., Monyror, J., Galleguillos, D., Steinberg, N., Kadam, V. Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front. Neurosci. 14, 572965. https:\/\/doi.org\/10.3389\/fnins.2020.572965.","DOI":"10.3389\/fnins.2020.572965"},{"key":"1745_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ymgme.2019.12.012","volume":"129","author":"FM Lang","year":"2020","unstructured":"Lang, F. M., Korner, P., Harnett, M., Karunakara, A. & Tifft, C. J. The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis. Mol. Genet Metab. 129, 228\u2013235 (2020).","journal-title":"Mol. Genet Metab."},{"key":"1745_CR5","first-page":"663","volume":"13","author":"DS Regier","year":"2016","unstructured":"Regier, D. S., Proia, R. L., D\u2019Azzo, A. & Tifft, C. J. The GM1 and GM2 gangliosidoses: natural history and progress toward therapy. Pediatr. Endocrinol. Rev. 13, 663\u2013673 (2016).","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"1745_CR6","doi-asserted-by":"publisher","unstructured":"Rha, A.K., Maguire, A.S., Martin, D.R. GM1 gangliosidosis: mechanisms and management. Appl. Clin. Genet. 14, 209\u2013233. https:\/\/doi.org\/10.2147\/TACG.S206076. (2021).","DOI":"10.2147\/TACG.S206076"},{"key":"1745_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101144","volume":"26","author":"P D\u2019Souza","year":"2024","unstructured":"D\u2019Souza, P. et al. GM1 gangliosidosis type II: Results of a 10year prospective study. Genet Med 26, 101144 (2024).","journal-title":"Genet Med"},{"key":"1745_CR8","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/mds.20193","volume":"19","author":"U Muthane","year":"2004","unstructured":"Muthane, U. et al. Clinical features of adult GM1 gangliosidosis: report of three Indian patients and review of 40 cases. Mov. Disord. 19, 1334\u20131341 (2004).","journal-title":"Mov. Disord."},{"key":"1745_CR9","doi-asserted-by":"crossref","unstructured":"Nicoli, E.R. et al. GM1 Gangliosidosis: a mini-review. Front. Genet. 12, 734878. (2021).","DOI":"10.3389\/fgene.2021.734878"},{"key":"1745_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/neurosci6020031","volume":"6","author":"CJ Lewis","year":"2025","unstructured":"Lewis, C. J. et al. A case for automated segmentation of MRI data in neurodegenerative diseases: Type II GM1 gangliosidosis. NeuroSci 6, 31 (2025).","journal-title":"NeuroSci"},{"key":"1745_CR11","doi-asserted-by":"publisher","unstructured":"Kolstad, J. et al. Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients [published correction appears in Mol Genet Metab. 2025 Apr 17:109109. 10.1016\/j.ymgme.2025.109109.]. 144, 109025. https:\/\/doi.org\/10.1016\/j.ymgme.2025.109025. (2025).","DOI":"10.1016\/j.ymgme.2025.109025"},{"key":"1745_CR12","doi-asserted-by":"publisher","unstructured":"Zoppo, C, et al. Quantitative reliability assessment of brain MRI volumetric measurements in Type II GM1 gangliosidosis patients. Front. Neuroimaging. 3:1410848. Published 2024 Sep 13. https:\/\/doi.org\/10.3389\/fnimg.2024.1410848. (2024).","DOI":"10.3389\/fnimg.2024.1410848"},{"key":"1745_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ymgme.2017.12.432","volume":"123","author":"I Nestrasil","year":"2018","unstructured":"Nestrasil, I. et al. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study. Mol. Genet Metab. 123, 97\u2013104 (2018).","journal-title":"Mol. Genet Metab."},{"key":"1745_CR14","doi-asserted-by":"publisher","first-page":"13251327","DOI":"10.3174\/ajnr.A1508","volume":"30","author":"E De Grandis","year":"2009","unstructured":"De Grandis, E., Di Rocco, M., Pessagno, A., Veneselli, E. & Rossi, A. MR imaging findings in 2 cases of late infantile GM1 gangliosidosis. AJNR Am. J. Neuroradiol. 30, 13251327 (2009).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1745_CR15","first-page":"16281630","volume":"19","author":"CY Chen","year":"1998","unstructured":"Chen, C. Y. et al. Neuroimaging findings in late infantile GM1 gangliosidosis. AJNR Am. J. Neuroradiol. 19, 16281630 (1998).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1745_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2013.02.003","volume":"49","author":"JP Vieira","year":"2013","unstructured":"Vieira, J. P., Concei\u00e7\u00e3o, C. & Scortenschi, E. GM1 gangliosidosis, late infantile onset dystonia, and T2 Hypointensity in the globus pallidus and substantia Nigra. Pediatr. Neurol. 49, 195\u2013197 (2013).","journal-title":"Pediatr. Neurol."},{"key":"1745_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ajmg.a.37468","volume":"170","author":"DS Regier","year":"2016","unstructured":"Regier, D. S. et al. MRI\/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis. Am. J. Med. Genet. A 170, 634\u2013644 (2016).","journal-title":"Am. J. Med. Genet. A"},{"key":"1745_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf198","volume":"7","author":"CJ Lewis","year":"2025","unstructured":"Lewis, C. J. et al. Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseases. Brain Commun. 7, fcaf198 (2025).","journal-title":"Brain Commun."},{"key":"1745_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1392683","volume":"18","author":"D Foster","year":"2024","unstructured":"Foster, D., Williams, L., Arnold, N. & Larsen, J. Therapeutic developments for neurodegenerative GM1 gangliosidosis. Front Neurosci. 18, 1392683 (2024).","journal-title":"Front Neurosci."},{"key":"1745_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.omtm.2019.11.023","volume":"17","author":"HL Gray-Edwards","year":"2019","unstructured":"Gray-Edwards, H. L. et al. 7T MRI predicts amelioration of neurodegeneration in the brain after AAV gene therapy. Mol. Ther. Methods Clin. Dev. 17, 258\u2013270 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1745_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/brain\/awab309","volume":"145","author":"AL Gross","year":"2022","unstructured":"Gross, A. L. et al. Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis. Brain 145, 655\u2013669 (2022).","journal-title":"Brain"},{"key":"1745_CR22","unstructured":"National Human Genome Research Institute. Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders ClinicalTrials.gov identifier: NCT00029965. Updated August 7, 2024. Accessed August 12, 2024. https:\/\/clinicaltrials.gov\/study\/NCT00029965. (2024)."},{"key":"1745_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2020.105224","volume":"29","author":"JE Reynolds","year":"2020","unstructured":"Reynolds, J. E., Long, X., Paniukov, D., Bagshawe, M. & Lebel, C. Calgary Preschool magnetic resonance imaging (MRI) dataset. Data Brief. 29, 105224 (2020).","journal-title":"Data Brief."},{"key":"1745_CR24","doi-asserted-by":"publisher","unstructured":"Reynolds, J, et al. Calgary Preschool MRI Dataset. https:\/\/doi.org\/10.17605\/OSF.IO\/AXZ5R.","DOI":"10.17605\/OSF.IO\/AXZ5R"},{"key":"1745_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-023-02038-w","volume":"10","author":"LT Strike","year":"2023","unstructured":"Strike, L. T. et al. The Queensland Twin Adolescent Brain Project, a longitudinal study of adolescent brain development. Sci. Data 10, 195 (2023).","journal-title":"Sci. Data"},{"key":"1745_CR26","doi-asserted-by":"publisher","unstructured":"Strike, L.T. et al. Queensland Twin Adolescent Brain (QTAB). OpenNeuro [Dataset] https:\/\/doi.org\/10.18112\/openneuro.ds004146.v1.0.4. (2022).","DOI":"10.18112\/openneuro.ds004146.v1.0.4"},{"key":"1745_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/cercor\/bhy002","volume":"29","author":"LT Strike","year":"2019","unstructured":"Strike, L. T. et al. Genetic Complexity of Cortical Structure: Differences in Genetic and Environmental Factors Influencing Cortical Surface Area and Thickness. Cereb. Cortex 29, 952\u2013962 (2019).","journal-title":"Cereb. Cortex"},{"key":"1745_CR28","doi-asserted-by":"publisher","unstructured":"Strike, L.T. et al. Queensland Twin IMaging (QTIM). OpenNeuro. (2022). [Dataset] https:\/\/doi.org\/10.18112\/openneuro.ds004169.v1.0.6.","DOI":"10.18112\/openneuro.ds004169.v1.0.6"},{"key":"1745_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jneumeth.2016.03.001","volume":"264","author":"X Li","year":"2016","unstructured":"Li, X., Morgan, P. S., Ashburner, J., Smith, J. & Rorden, C. The first step for neuroimaging data analysis: DICOM to NIfTI conversion. J. Neurosci. Methods 264, 47\u201356 (2016).","journal-title":"J. Neurosci. Methods"},{"key":"1745_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.26558","volume":"45","author":"HD Nguyen","year":"2024","unstructured":"Nguyen, H. D., Cl\u00e9ment, M., Mansencal, B. & Coup\u00e9, P. Brain structure ages-A new biomarker for multi-disease classification. Hum. Brain Mapp. 45, e26558 (2024).","journal-title":"Hum. Brain Mapp."},{"key":"1745_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117026","volume":"219","author":"P Coup\u00e9","year":"2020","unstructured":"Coup\u00e9, P. et al. AssemblyNet: A large ensemble of CNNs for 3D whole brain MRI segmentation. Neuroimage 219, 117026 (2020).","journal-title":"Neuroimage"},{"key":"1745_CR32","doi-asserted-by":"publisher","first-page":"225022","DOI":"10.1088\/1361-6560\/abb6be","volume":"65","author":"B Denis de Senneville","year":"2020","unstructured":"Denis de Senneville, B., Manj\u00f3n, J. V. & Coup\u00e9, P. RegQCNET: Deep quality control for image-to-template brain MRI affine registration. Phys. Med Biol. 65, 225022 (2020).","journal-title":"Phys. Med Biol."},{"key":"1745_CR33","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner, J. & Targum, S. D. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry 4, 28\u201337 (2007).","journal-title":"Psychiatry"},{"key":"1745_CR34","doi-asserted-by":"crossref","unstructured":"Guy, W. ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service, (1976).","DOI":"10.1037\/e591322011-001"},{"key":"1745_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03614-6","volume":"20","author":"CJ Lewis","year":"2025","unstructured":"Lewis, C. J. et al. Retrospective assessment of clinical global impression of severity and change in GM1 gangliosidosis: a tool to score natural history data in rare disease cohorts. Orphanet J. Rare Dis. 20, 125 (2025).","journal-title":"Orphanet J. Rare Dis."},{"key":"1745_CR36","doi-asserted-by":"publisher","unstructured":"Sparrow, S.S., Cicchetti, D., Balla, D.A. Vineland Adaptive Behavior Scales, Second Edition (Vineland-II) [Database record]. APA PsycTests. https:\/\/doi.org\/10.1037\/t15164000. (2005).","DOI":"10.1037\/t15164000"},{"key":"1745_CR37","unstructured":"Sparrow, S.S., Cicchetti, D.V., Saulnier, C.A. Vineland adaptive behavior scales, Third edition (Vineland-3). Bloomington: NCS Pearson. (2016)."},{"key":"1745_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1\u201348 (2015).","journal-title":"J. Stat. Softw."},{"key":"1745_CR39","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1002\/hbm.25968","volume":"43","author":"N Mittal","year":"2022","unstructured":"Mittal, N. et al. Effect of neuroanatomy on corticomotor excitability during and after transcranial magnetic stimulation and intermittent theta burst stimulation. Hum. Brain Mapp. 43, 4492\u20134507 (2022).","journal-title":"Hum. Brain Mapp."},{"key":"1745_CR40","doi-asserted-by":"publisher","unstructured":"Lewis, C.J. et al. The relationship of neuroanatomy on resting motor threshold and induced electric field strength on treatment outcomes in mild to moderate traumatic brain injury patients during transcranial magnetic stimulation. AIP Adv.13, https:\/\/doi.org\/10.1063\/9.0000567. (2023).","DOI":"10.1063\/9.0000567"},{"key":"1745_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/bfgp\/elae042","volume":"24","author":"M Azzam","year":"2025","unstructured":"Azzam, M. et al. A review of artificial intelligence-based brain age estimation and its applications for related diseases. Brief. Funct. Genomics 24, elae042 (2025).","journal-title":"Brief. Funct. Genomics"},{"key":"1745_CR42","doi-asserted-by":"crossref","unstructured":"Uchino, A, et al. An autopsy case of GM1 gangliosidosis type II in a patient who survived a long duration with artificial respiratory support. Neuropathology. 40, 379\u2013388. (2020).","DOI":"10.1111\/neup.12651"},{"key":"1745_CR43","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/mp.2017.62","volume":"23","author":"JH Cole","year":"2018","unstructured":"Cole, J. H. et al. Brain age predicts mortality. Mol. Psychiatry 23, 1385\u20131392 (2018).","journal-title":"Mol. Psychiatry"},{"key":"1745_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54657-5","volume":"15","author":"H Sun","year":"2024","unstructured":"Sun, H. et al. Brain age prediction and deviations from normative trajectories in the neonatal connectome. Nat. Commun. 15, 10251 (2024).","journal-title":"Nat. Commun."},{"key":"1745_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biopsych.2024.07.019","volume":"97","author":"D Beck","year":"2025","unstructured":"Beck, D. et al. Dimensions of early-life adversity are differentially associated with patterns of delayed and accelerated brain maturation. Biol. Psychiatry 97, 64\u201372 (2025).","journal-title":"Biol. Psychiatry"},{"key":"1745_CR46","doi-asserted-by":"publisher","unstructured":"Cropley, V.L. et al. Brain-predicted age associates with psychopathology dimensions in youths. Biol. Psychiatry Cogn. Neurosci. Neuroimaging. 6, 410-419. https:\/\/doi.org\/10.1016\/j.bpsc.2020.07.014. (2021).","DOI":"10.1016\/j.bpsc.2020.07.014"},{"key":"1745_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hbm.25364","volume":"43","author":"S Frangou","year":"2022","unstructured":"Frangou, S. et al. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90\u2009years. Hum. Brain Mapp. 43, 431\u2013451 (2022).","journal-title":"Hum. Brain Mapp."},{"key":"1745_CR48","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1038\/s41380-023-02157-1","volume":"28","author":"M Filippi","year":"2023","unstructured":"Filippi, M. et al. Age-related vulnerability of the human brain connectome. Mol. Psychiatry 28, 5350\u20135358 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1745_CR49","doi-asserted-by":"publisher","unstructured":"Soumya Kumari, LK, Sundarrajan, R. A review on brain age prediction models. Brain Res. 1823:148668. https:\/\/doi.org\/10.1016\/j.brainres.2023.148668. (2024).","DOI":"10.1016\/j.brainres.2023.148668"},{"key":"1745_CR50","doi-asserted-by":"crossref","unstructured":"Lewis, C. J. et al. AAV9 gene therapy in type II GM1 gangliosidosis - A phase 1\u20132 trial. N. Engl. J. Med. 394, 1184\u20131194 (2026).","DOI":"10.1056\/NEJMoa2510935"},{"key":"1745_CR51","first-page":"836843","volume":"3","author":"TT Le","year":"2018","unstructured":"Le, T. T. et al. Effect of Ibuprofen on BrainAGE: a randomized, placebo-controlled, dose-response exploratory study. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 3, 836843 (2018).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"1745_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.712565","volume":"12","author":"KM Kinnunen","year":"2021","unstructured":"Kinnunen, K. M. et al. Recommendations to optimize the use of volumetric MRI in Huntington\u2019s Disease Clinical Trials. Front Neurol. 12, 712565 (2021).","journal-title":"Front Neurol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01745-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:22:59Z","timestamp":1793276579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01745-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01745-w","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"568"}}